Asia-Pacific Hospital Beds Market Growth Factors, Consumption, Market Current Scenario, 2023

Europe Hospital Bed MarketThe Asia Pacific hospital bed market size was $1.3 billion in 2015 and is forecasted to grow at a CAGR of 5.2% during the period 2016-2022. General beds have been witnessing the fastest growth, and are projected to grow at a CAGR of 5.6%, during the forecast period, among the various types of beds available in the market namely, birthing beds, pediatric beds, bariatric beds, pressure relief beds and others.

Some of the significant factors driving the hospital bed market in the region include, surge in the aging population, rising prevalence of chronic diseases, and improving hospital infrastructure.

Hospital beds are being utilized for various types of treatments such as acute care, critical care and long-term beds, acute care beds held the largest share of the hospital bed market in the region, in 2015.

Increase in diabetes causes numerous diseases to a human being such as cardiovascular diseases, nerve damage, kidney damage, skin conditions and others, due to which the patients need to be admitted in the hospital at times for monitoring and treatment. According to the Asian Diabetes Prevention Initiative, around 60% of diabetics in the world live in Asia. It is also expected that without intervention, both China and India combined are likely to have almost half a billion of population suffering from diabetes, by 2030.

Some of the key players operating in the Asia-Pacific hospital bed industry are Hill-Rom Holdings Inc., Stryker Corporation, Paramount Bed Co. Ltd., SEAHONENCE, INC., FRANCE BED HOLDINGS Co. Ltd., Guangdong Kareway Medical Technology Co. Ltd., Jiangsu Aegean Technology Co. Ltd., Midmark Corporation, Nanning Passion Medical Equipment Co. Ltd. and Carevel Medical Systems Private Limited.

News Courtesy: P&S Market Research


Benign Prostatic Hyperplasia Treatment Devices Growth Factors, Consumption & Market Current Scenario

Benign Prostatic Hyperplasia Treatment Devices Market

The global benign prostatic hyperplasia treatment devices market is expected to experience an extensive growth in the coming years due to various factors such as increasing aging population, rising prevalence of benign prostatic hyperplasia, increasing awareness about benign prostatic hyperplasia treatment procedures and surge in the adoption of minimally invasive procedures. BPH devices have been classified on the basis of different procedures for which these are used such as, transurethral resection of the prostate (TURP), transurethral incision of the prostate (TUIP); laser based procedures such as green light lasers, holmium lasers, thulium lasers surgery; and energy-based procedures such as transurethral microwave thermotherapy (TUMT), transurethral needle ablation (TUNA), high-intensity focused ultrasound (HIFU) & water-induced thermotherapy; and other procedures.

Laser based procedures are expected to register the fastest growth in the benign prostatic hyperplasia treatment devices market during the forecast period, since these procedures are as effective as surgical procedures, reduce the hospital stay time and do not leave any scars post treatment. Benign prostatic hyperplasia refers to the enlargement of the prostate gland which obstructs the passage of urine through urethra in men. The disease is more common in aging men, and about half of all men between the age of 51 to 60 years suffer from the disease.

Growing aging population, rising prevalence of benign prostatic hyperplasia, rise in the awareness about various benign prostatic hyperplasia disorders and surge in the adoption of minimally invasive procedures are the some of the major factors driving the demand for benign prostatic hyperplasia treatment devices.

Reimbursement for benign prostatic hyperplasia procedures and growing healthcare market in emerging countries provides ample growth opportunities to the players operating in the benign prostatic hyperplasia treatment devices industry.

In March 2017, NeoTract Inc. announced the expansion of its minimally invasive procedure device, UroLift System, to be available in Ireland. The geographical expansion of the product in Ireland was supported by Vhi group, a private health insurance firm. In June 2017, Olympus Corporation announced the expansion of its PLASMA Resection in Africa that provides clinical benefits and cost saving procedure, in comparison to monopolar TURP.In September 2016, NeoTract, Inc. announced that the company has received the de novo approval from USFDA for its UroLift System for prostate implant.

News Courtesy: P&S Market Research

Rehab Equipment Worldwide Market Size, Revenue, Growth rate and Future Analysis

Rehab Equipment Market

Rehab equipment are re-usable equipment which aid patients in their daily chores. It is one of the effective ways to treat a patient recovering from long-term injury or illness. It accelerates the recovery process of the patient. Over the last decade, there has been a considerable growth in the global rehab equipment market due to advancement in technology and government reforms such as long-term care insurance, 2000 in Japan. It is expected to grow further during the forecast period (2017-2023) due to the entry of various private and government insurance players in the market. These players will provide reimbursement plans for the rehab equipment that will make these equipment more affordable.

Companies are focusing on the technological advancements which is causing rapid growth of the market. The key factors which drive the growth of the global rehab equipment markets are positive government healthcare reforms, aging population and rise in chronic diseases, increase in disabilities due to non-communicable diseases, rise in disabled population and increasing sports injuries.

Due to introduction of the long-term care insurance system in the industry, interest in rehab equipment of the users has increased which later became a trend in the market. This trend further drives the market for the improvement in function and design of the equipment which will be of great importance for the aged and physically challenged population.

The key trend in the global rehab equipment market is physiotherapy due to aging population, increase in disabilities and usage of daily living aids for the proper and comfortable treatment of the patients.

Other key players in global rehab equipment market are Medline Industries, Inc., Dynatronics Corporation, GMS Rehabilitation, Drive DeVilbiss Healthcare, Changzhou Qian Jing Rehabilitation Co., Ltd., Compass Health Brands, Roma Medical, Caremax Rehabilitation Equipment Co. Ltd., GF Health Products, Inc., and Hospital Equipment Manufacturing Company.

News Courtesy: P&S Market Research

North America Stands as the Largest Radiation Dose Management Market till 2023

Radiation Dose Management Market AnalysisThe global radiation dose management market is likely to develop at a CAGR of 46.0% during 2017-2023. RDM solutions and services are offered for various imaging modalities such as computed tomography (CT), nuclear medicine, fluoroscopy and interventional imaging, radiography and mammography, and others. RDM solutions and services are mostly utilized for monitoring radiation dose in CT. Globally, certain standards have been set up by the government to avoid high dose of radiation and have linked these doses to reimbursements, so that the radiologists give priority to the new guidelines. For instance, in 2014, National Equipment Manufacturers Association (NEMA) established certain guidelines under XR-29, for promoting low radiation dose standards. According to these guidelines, if the dose standards for CT are not followed it can bring down the reimbursement, as much as 15% for CT scanners that don’t meet the standards set forward by XR-29. Therefore, stringent regulatory requirements for diagnostic techniques supports the demand for RDM solutions and services.

RDM solutions occupied the larger share of the global market in 2016, since these solutions enable the healthcare providers to track and evaluate the radiations emitting from different diagnostic procedures. The players in the industry provide services such as implementation and integration, support and maintenance, consulting and training and education. Among all the services, implementation and integration held the largest share of the market in 2016, since these services are associated with installation of solutions and integration with other systems in the healthcare settings.

Geographically, North America has been the largest market for RDM, with the U.S. being the larger contributor to the regional market, as compared to Canada. The leading position of the North American market is mainly attributable to the high number of CT examinations performed, increasing prevalence of chronic diseases and rising adoption of radiation dose management software in the region. The Medical Imaging and Technology Alliance (MITA) has taken aggressive efforts to optimize patient dose across the industry in the U.S., which is further expected to increase the demand for RDM solutions in the region.

Globally, the key players in the market are introducing new solutions with advanced features in the market. For instance, in November 2016, Koninklijke Philips N.V. introduced DoseWise Portal 2.2, a next-generation radiation dose management software platform for healthcare providers to record, track and analyse radiation exposure to patients and clinicians.

News Courtesy: P&S Market Research

North America Sleeping Aids Market Scenario, Leading Players, Segments Analysis and Growth Drivers to 2022

Sleeping Aids MarketThe global sleeping aids market is increasing, due to growing geriatric population and increasing awareness about sleep disorders by various organizations. Older people are more prone to sleep disorders, such as obstructive sleep apnea and insomnia. In addition, the lifestyle changes are leading to sleep disorder, due to the increased usage of caffeine, tobacco and alcohol. This has generated the demand for sleeping aids products. The long working hours and hectic work environment further hampers the quality of sleep, which is leading to an increased consumption of OTC drugs, thus encouraging the growth of the global sleeping aids market.

Among the various sleep disorders, the sleep apnea market segment is expected to witness the fastest growth in the global market during the forecast period. Among the various sleeping aids products, the mattress and pillows segment had the largest market size in the global market during 2015; however the sleep apnea devices segment is expected to witness fastest growth, at 6.9% CAGR during the period 2016 – 2022.

The various government and non-government organizations are taking initiatives to spread awareness about the importance of sound sleep and use of sleep aids products. The governments of various countries are taking initiatives to encourage the use of sleeping aids products, as these products help patients to reduce sleeping disorders. The increasing initiative to create awareness about the importance of adequate sleep and educating people about sleep disorders are also driving the growth of the global market.

The key companies operating in the global sleeping aids market include Sanofi, Merck & Co., Pfizer Inc., Koninklijke Philips N.V, GlaxoSmithKline PLC, SleepMed Inc., Cadwell Laboratories Inc., Drive Medical Ltd., Natus Medical Incorporated, Takeda Pharmaceutical Company Limited, Compumedics Limited, CareFusion Corporation, and Teva Pharmaceutical Industries Ltd.

News Courtesy: P&S Market Research

Protein Expression Market is Driven by Growth in Pharmaceutical and Biotechnology Industry

Major key players in the market are developing products with technically advanced features that are designed to produce high protein yield, maintaining a balance of speed and scalability, thereby enhancing its application in the drug development workflow.

Some of the recent advanced product launched by the major players in the market include Gibco ExpiCHO expression system, launched in 2015 by ThermFisher Scientific Inc., that offers an increase yield of over 100-fold, thereby enabling upto 3g/L of protein yield; in comparison to its previous CHO system. Therefore, technically advanced products are a major factor driving the growth of the market during the forecast period.

Download Report Sample at:

Protein Expression market

Geographically, North America has been the largest market for protein expression, with the U.S. being the larger contributor to the regional market, as compared to Canada. The dominant position of the North American market is mainly attributable to the rise in R&D infrastructure, increased aging population, rise in healthcare expenditure and increasing prevalence of chronic diseases in the region.

Europe is the second largest market for protein expression, after North America. The Germany has been the largest contributor to the European protein expression market, followed by the U.K. and France. The growth of the European market is mainly attributable to the growing aging population, increase in infections, rising incidences of cardiovascular diseases, chronic pain, and neurological disorders and R&D infrastructure. The protein expression market is expected to witness the fastest growth in Asia-Pacific during forecast period. Rising prevalence of diseases such as cardiovascular disease and diabetes, increasing R&D spending, growing aging population and increasing per capita income are some of the driving factors boosting the Asia-Pacific market.

Key players are launching new products in the market to offer advanced protein expression products. In August 2017, Thermo Fisher Scientific Inc. launched Thermo Scientific Krios G3i which is designed to deliver innovative enhancements necessary for rapid adoption of cryo-EM. The Thermo Scientific Krios G3i can be used independently or together in a single particle analysis workflow to make structural analysis of the proteins, protein complexes and other biomolecular structures faster, easier and more accessible.

Make Enquiry Before Buying the Report:

In July 2017, Agilent Technologies Inc. expanded its portfolio of instruments for molecular diagnostics with the introduction of the AriaDx Real-Time PCR System. Real-time polymerase chain reaction (PCR) is routinely used in laboratories to help identify pathogens, genotype infectious agents, and for cancer diagnostics. The open platform of AriaDx makes it compatible to existing fast chemistry-based assays that are DNA binding and probe-based. This feature enables assay developers and partners with optimized reaction chemistries to quickly validate their assays on the AriaDx.

Some of the other key players operating in this industry include Merck KGaA, Genscript Biotech Corporation, Agilent Technologies, Inc., Promega Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., New England Biolabs Inc., and Lonza Group Ltd.


 P&S Market Research

347, 5th Ave. #1402

New York City, NY – 10016

Toll-free: +18887787886 (USA/Canada)



Connect with us: LinkedIn | Twitter | Google + | Facebook

Orthodontic Supplies Market Analysis, Drivers, Restraints, Opportunities and Challenges

Orthodontic Supplies MarketThe global orthodontic supplies market is likely to grow from $3.4 billion in 2016 to $5.9 billion by 2023. The demand for orthodontic supplies is on a surge mainly due to increasing prevalence of oral diseases. Some of the most common oral diseases include dental cavities, periodontal diseases, oral cancer, malocclusions and other oral diseases and disorders. High prevalence of oral diseases depicts increased demand for orthodontic supplies. According to the World Health Organization (WHO), around 60% to 90% of the school children and nearly 100% of adults suffer from dental cavities. It has also been observed that, around 15% to 20% of adults aged between 35 to 44 years, suffer from severe periodontal (gum) disease.

As per the findings of the research, based on product, the fixed braces held the largest share in the global orthodontic supplies market, primarily due to their efficacy and precision in treating the irregularities in dental structure. Removable braces are expected to register the fastest growth in the orthodontics supplies market during the forecast period. The growth of the removable braces is primarily attributable to increase in the adoption of these braces by adults over traditional braces. Based on end user, children & teenagers are the larger end user in the orthodontic supplies market. Orthodontic treatments are more effective and successful in childhood or teenage as treatment at early age also prevents the development of serious problems, thereby leading to the larger adoption of orthodontic supplies at this age. The orthodontic supplies market for adults is expected to witness higher growth during the forecast period, mainly due to the increasing investment for the development of aesthetic braces and rising awareness about orthodontic treatment.

Cosmetic orthodontics is a procedure where the treatment is done to improve the appearance of a person’s gums, teeth and bite. The primary focus of the treatment is to alter the color, shape, and alignment of the teeth. With the growing inclination towards appearance, cosmetic orthodontics has become a preferable treatment option. Many technological advancements have been made in the orthodontics supplies products to make a person’s appearance better, both during and after the treatment. Some of these advancements include transparent brackets for professional look, colored brackets for children, and lingual brackets.

Some of the other key players operating in the orthodontics supplies market include 3M Company, Danaher Corporation, G&H Orthodontics Inc., American Orthodontics, TP Orthodontics Inc., Rocky Mountain Orthodontics, Dentaurum GmbH & Co. Kg and DB Orthodontics Inc.

News Courtesy: P&S Market Research

Thermoplastic Elastomers Contribute Larger Revenue to the Global Automotive Elastomers Market

Elastomers are materials which are made of polymers that are joined by chemical bonds, acquiring a final slightly cross-linked structure. Elastomers are any rubbery material composed of long chainlike molecules, or polymers, that are capable of recovering their original shape after being stretched to great extents—hence the name elastomer has been derived from “elastic polymer.” Automotive elastomers are the elastomers used for manufacturing different automotive parts. The global automotive elastomers market is expected to witness considerable growth due to the increasing demand for high efficiency vehicles and growing automotive industry.

Under normal conditions, the long molecules making up an elastomeric material are irregularly coiled; however, with the application of force, the molecules straighten out in the direction in which they are being pulled. Upon release, the molecules spontaneously return to their normal compact and random arrangement. Elastomer rubber compounds are made from five to ten ingredients, each ingredient playing a specific role. Polymer is the main component and determines heat and chemical resistance as well as low-temperature performance. Elastomers are integrated with reinforcing filler (carbon black) for strength properties and plasticizer for improving low-temperature properties. Other ingredients include anti-oxidants, release package, scorch retarder, curative and an accelerator.

The global automotive elastomers market was valued at $10,015.2 million in 2015, and it is expected to grow at a CAGR of 5.9% during the forecast period (2016 – 2022). High emphasis on lightweight materials, stringent emission regulations, increasing demand for high-efficiency vehicles, and growth in automotive industry are the major factors driving the growth of the global automotive elastomers market. The global automotive elastomers market faces challenges such as price volatility and lack of balance between automotive elastomers performance and cost.

The growing economies and improving standards of living in countries such as China and India are the factors resulted in increased sale volumes. The use of elastomers in cars manufactured in Asia-Pacific is less, as compared to North America and Europe; however, the high production volume in Asia-Pacific has made it an attractive  automotive elastomers market. The increasing industrialization has increased the overall purchasing power of consumers. According to the National Bureau of Statistics of China, the annual per capita disposable income of urban households in China increased from $2,818.6 in 2010 to $4,692.9 in 2014. The per capita GDP of India increased from $1,432.3 in 2010 to $1,500.8 in 2012, and is expected to reach $1,869.3 by 2018.

Some of the other key players in the global automotive elastomers market include BASF SE, LANXESS AG, E. I. du Pont de Nemours and Company, LyondellBasell Industries N.V., The Dow Chemical Company, Huntsman International LLC, 3M Company, China Petrochemical Corporation, and Kuraray Co. Ltd.

News Courtesy: P&S Market Research

Ethylene Market Growth Till 2023

The global ethylene market is driven by growth in the use of polyethylene mainly for consumables; ethylene glycol/oxide for polyethylene terephthalate (PET) resins for PET fiber, bottles and other packaging; and ethylene dichloride for PVC plastic uses in construction and pipe. Polyethylene, the largest ethylene derivative, accounts for majority of the global ethylene consumption. Markets of polyethylene include film, packaging, containers and articles for home and light industrial use.

Ethylene is a colorless flammable gas with a musky odor. It is the simplest alkene and unsaturated hydrocarbon after acetylene. It is extensively used in agriculture as a plant hormone to ripen fruits; it is also used in the chemical industry to produce ethyl benzene, polyethylene, ethylene dichloride, and ethylene oxide among others. The ethylene production methods include steam cracking of paraffinic hydrocarbons or by separation from refinery gas. Industrial reactions of ethylene include alkylation, halogenation, polymerization, oxidation, hydro halogenation and others.

The production of textile fibers is growing significantly, especially in Asia-Pacific. In addition, producers of ethylene oxide have already been able to profit from the worldwide growing substitution of glass by PET bottles and containers. Furthermore, ethylene is used as a welding gas and as an anesthetic agent.

On the basis of applications of ethylene, the global ethylene market has been  segmented into high density polyethylene (HDPE),  low-density polyethylene (LDPE) and linear low density polyethylene (LLDPE), and intermediates of petrochemicals, mainly used for the production of plastics. The most important of these are ethylene dichloride and ethylbenzene and ethylene oxide.

As ethylene is combustible and carcinogenic, stringent regulations on the use of ethylene are expected to hamper the ethylene market. In addition, volatility in the feedstock cost along with rising competition within industry players also obstructs the growth of global ethylene market.

Some of the major competitors of the global ethylene market are Equistar Chemicals, BASF SE, LP, ExxonMobil Corporation, Chevron Phillips Chemical Company, The Dow Chemical Company, Formosa Plastics Corporation, U.S.A., INEOS, Sasol Ltd, Shell Chemical LP and Westlake Chemical Corporation among others.

News Courtesy : P&S Market Research


Spinal Muscular Atrophy Therapeutics – Pipeline Analysis, Clinical Trials & Results, 2017

Spinal Muscular Atrophy Therapeutics Pipeline Analysis

The study analyzed that the therapeutics pipeline comprises approximately 16 drug candidates in different stages of development. Spinal muscular atrophy is defined as the inherited genetic disease that is characterized by a failure of nerve cells called motor neurons. Motor neurons are responsible to accept the nerve impulses transmitted from the brain to the spinal cord and transmit the impulses to the muscle with the help of peripheral nerves. The loss of motor neurons leads to muscle weakness in muscles that are closest to the trunk of the body such as back, hips and shoulders.

Imago Pharmaceuticals, Inc. is using nucleic acid therapeutics technology platform for the treatment of spinal muscular atrophy. Nucleic acid therapeutics technology includes large and innovative class of drugs that can modulate the function of target ribonucleic acid, or RNA, to ultimately affect the production of disease-associated proteins. Nucleic acid therapeutics comprise of complex mixtures of various chemical entities known as stereoisomers. Some stereoisomers in these mixtures have therapeutic effects, while others are less beneficial or contribute to undesirable side effects. Uncontrolled stereoisomer drug mixtures can lead to suboptimal efficacy and increased risk and safety concerns.

Some of the other key players developing drugs for the treatment of spinal muscular atrophy include Cytokinetics, Inc., F. Hoffman La-Roche Ltd, WAVE Life Sciences Ltd. and others.

News Courtesy: P&S Market Research